- Featured Product
- KD/KO Validated
MCL1 Monoklonaler Antikörper
MCL1 Monoklonal Antikörper für WB, IHC, IF/ICC, Cytometric bead array, Indirect ELISA
Wirt / Isotyp
Maus / IgG2b
Getestete Reaktivität
human
Anwendung
WB, IHC, IF/ICC, Cytometric bead array, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1E3C2
Kat-Nr. : 66026-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66026-1-PBS bindet in WB, IHC, IF/ICC, Cytometric bead array, Indirect ELISA MCL1 und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Maus / IgG2b |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | MCL1 fusion protein Ag10609 |
Vollständiger Name | myeloid cell leukemia sequence 1 (BCL2-related) |
Berechnetes Molekulargewicht | 350 aa, 37 kDa |
Beobachtetes Molekulargewicht | 35 kDa |
GenBank-Zugangsnummer | BC107735 |
Gene symbol | MCL1 |
Gene ID (NCBI) | 4170 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
MCL-1 is an anti-apoptotic member of the Bcl-2 family originally isolated from the ML-1 human myeloid leukemia cell line. Similar to BCL2 and BCL2L1, MCL1 can interact with BAX and/or BAK1 to inhibit mitochondria-mediated apoptosis. Mcl-1 is critical for the proliferation and survival of myeloma cells in vitro, and overexpression of Mcl-1 protein in myeloma cells is associated with relapse and short event-free survival in multiple myeloma patients. Recent studies show that MCL-1 is upregulated in numerous haematological and solid tumour malignancies. Therefore, MCL-1 has been suggested as a potential new therapeutic target.